Humacyte (HUMAW) Competitors

$0.57
-0.04 (-6.56%)
(As of 04/26/2024 ET)

HUMAW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Humacyte stock or one of its competitors? The main competitors of Humacyte include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Humacyte vs.

Humacyte (NASDAQ:HUMAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends, community ranking and analyst recommendations.

Humacyte and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
HumacyteN/AN/A
180 Life SciencesN/AN/A

In the previous week, Humacyte had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Humacyte and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.00 beat Humacyte's score of 0.50 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Humacyte Positive
180 Life Sciences Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humacyte
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HumacyteN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
HumacyteN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

Humacyte and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUMAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HUMAW vs. The Competition

MetricHumacyteBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.07B$4.88B$7.55B
Dividend YieldN/A3.61%2.91%3.95%
P/E RatioN/A65.29232.4819.19
Price / SalesN/A14,084.202,338.7085.76
Price / CashN/A11.8947.0434.73
Price / BookN/A5.374.764.33
Net IncomeN/A$15.85M$103.54M$214.22M
7 Day Performance-4.57%0.95%0.74%1.88%
1 Month Performance-21.26%-4.92%-7.60%-5.23%
1 Year Performance-4.98%47.21%9.25%8.41%

Humacyte Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-41.5%$0.00N/A0.004Short Interest ↓
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.11
flat
N/AN/A$0.00$253,573.000.002Positive News
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.21
flat
N/A-4.6%$0.00N/A0.00121Short Interest ↓
Positive News
APLMW
Apollomics
0 of 5 stars
$0.03
+66.7%
N/AN/A$0.00N/A0.0059Short Interest ↓
News Coverage
Gap Up
ARTLW
Artelo Biosciences
0 of 5 stars
$0.02
flat
N/AN/A$0.00N/A0.005Positive News
BCDAW
BioCardia
0 of 5 stars
$0.02
-34.5%
N/AN/A$0.00$477,000.000.0030Positive News
Gap Down
BCTXW
BriaCell Therapeutics
0 of 5 stars
$1.01
-9.8%
N/A-68.6%$0.00N/A0.0016Positive News
Gap Down
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.07
-21.2%
N/A-76.2%$0.00$17,065.000.007Positive News
Gap Down
High Trading Volume
CTCXW
Carmell
0 of 5 stars
$0.07
-35.5%
N/AN/A$0.00$3.73M0.009Positive News
SAVAW
Cassava Sciences
0 of 5 stars
$0.87
+11.5%
N/AN/A$0.00N/A0.0029Positive News
Gap Down
High Trading Volume

Related Companies and Tools

This page (NASDAQ:HUMAW) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners